These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1093 related articles for article (PubMed ID: 422870)

  • 1. Selective toxicity of 6-hydroxydopa for melanoma cells.
    Wick MM; Byers L; Ratliff J
    J Invest Dermatol; 1979 Feb; 72(2):67-9. PubMed ID: 422870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective incorporation of L-3,4-dihydroxyphenylalanine by S-91 Cloudman melanoma in vitro.
    Wick MM; Frei E
    Cancer Res; 1977 Jul; 37(7 Pt 1):2123-5. PubMed ID: 861938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells.
    Morrison ME; Yagi MJ; Cohen G
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2960-4. PubMed ID: 3921968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of supplemental ascorbate on the antitumor activity of 5-hydroxydopa, a purported cytotoxic metabolite.
    Pierson HF; Meadows GG
    Cancer Lett; 1985 Nov; 29(2):157-68. PubMed ID: 3935310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-dopa: selective toxicity for melanoma cells in vitro.
    Wick MM; Byers L; Frei E
    Science; 1977 Jul; 197(4302):468-9. PubMed ID: 877570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of 6-hydroxydopa by human tyrosinase.
    Hansson C; Rorsman H; Rosengren E; Wittbjer A
    Acta Derm Venereol; 1985; 65(2):154-7. PubMed ID: 2408419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of DOPA-loading on glutathione-dependent 5-S-cysteinyldopa genesis in melanoma cells in vitro.
    Mojamdar M; Ichihashi M; Mishima Y
    J Invest Dermatol; 1982 Mar; 78(3):224-6. PubMed ID: 6799583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic amines are selective cytotoxic agents for pigmented cells.
    Noga EJ; Barthalmus GT; Mitchell MK
    Cell Biol Int Rep; 1986 Apr; 10(4):239-47. PubMed ID: 3708699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of clonogenic growth of melanoma cells by combination of melanocyte stimulating hormone and theophylline.
    Wick MM
    J Invest Dermatol; 1981 Sep; 77(3):253-5. PubMed ID: 7196427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective toxicity of 5-S-cysteinyldopa, a melanin precursor, to tumor cells in vitro and in vivo.
    Fujita K; Ito S; Inoue S; Yamamoto Y; Takeuchi J; Shamoto M; Nagatsu T
    Cancer Res; 1980 Jul; 40(7):2543-6. PubMed ID: 6771000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds.
    Ito S; Inoue S; Yamamoto Y; Fujita K
    J Med Chem; 1981 Jun; 24(6):673-7. PubMed ID: 6788955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between melanotic and amelanotic retinal pigment epithelial cells in vitro concerning the effects of L-dopa and oxygen on cell cycle.
    Akeo K; Tanaka Y; Okisaka S
    Pigment Cell Res; 1994 Jun; 7(3):145-51. PubMed ID: 7971747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Utilization of melanin precursors for experimental chemotherapy of malignant melanoma].
    Jimbow K; Miura S; Ito Y; Kasuga T; Ito S
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2125-32. PubMed ID: 6435538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular localization of tyrosinase inhibitor in amelanotic and melanotic malignant melanoma.
    Hamada T; Mishima Y
    Br J Dermatol; 1972 Apr; 86(4):385-94. PubMed ID: 4623455
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic control of melanization: isolation and analysis of amelanotic variants from cultured melanotic melanoma cells.
    Pawelek J; Sansone M; Morowitz J; Moellmann G; Godawska E
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1073-7. PubMed ID: 4364526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of tyrosinase regulation by L-dopa in hamster melanoma cells.
    Slominski A; Costantino R
    Life Sci; 1991; 48(21):2075-9. PubMed ID: 1903481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of melanoma cells by N-protected dopa derivatives.
    Inoue S; Ito S; Imai Y; Kasuga T; Fujita K
    Biochem Pharmacol; 1987 Oct; 36(20):3537-40. PubMed ID: 3118879
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of alpha-methyl-p-tyrosine on 3,4-dihydroxyphenylalanine (DOPA) excretion of hamsters with melanotic melanoma.
    Voorhess ML
    Cancer Res; 1968 Mar; 28(3):452-4. PubMed ID: 5640864
    [No Abstract]   [Full Text] [Related]  

  • 19. MSH binding in Bomirski amelanotic hamster melanoma cells is stimulated by L-tyrosine.
    Slominski A; Pawelek J
    Biosci Rep; 1987 Dec; 7(12):949-54. PubMed ID: 3134959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,4-Dihydroxybenzylamine: an improved dopamine analog cytotoxic for melanoma cells in part through oxidation products inhibitory to dna polymerase.
    FitzGerald GB; Wick MM
    J Invest Dermatol; 1983 Feb; 80(2):119-23. PubMed ID: 6401786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.